Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

by Medical Finance
in Coronavirus
Study: Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model. Image Credit: Teeradej/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

In a recent study posted to the bioRxiv* preprint server, the researchers compared the efficiency of monovalent and bivalent messenger ribonucleic acid (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Study: Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model. Image Credit: Teeradej/Shutterstock
Study: Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model. Image Credit: Teeradej/Shutterstock

Coronavirus disease 2019 (COVID-19) vaccines have contributed significantly to curbing the morbidity and mortality caused by the pandemic. With the emergence of novel SARS-CoV-2 variants, developing newer and more efficacious vaccines and vaccine strategies is essential.

About the study

In the present study, the team developed unmodified mRNA vaccines, including CV2CoV.351, CV2CoV.617, and CV2CoV, that encoded the SARS-CoV-2 spike protein sequences from the SARS-CoV-2 Beta (B.1.351) and Delta (B.1.617.2) variants as well as the wildtype strain. The monovalent vaccine consisted of either CV2CoV.351, CV2CoV.617, and CV2CoV, and the bivalent vaccine consisted of CV2CoV.351 and CV2CoV.617.

The team injected K18-human angiotensin-converting enzyme 2 (ACE2) transgenic mice with either 20 µL of a low dose of the monovalent or the bivalent vaccines or sodium chloride (NaCl) on day 0 and day 28. These transgenic mice are known to have a human-like ACE2 receptor which served as the entry point for SARS-CoV-2.

The vaccinated mice were protected from SARS-CoV-2 exposure, while the mice injected with NaCl were challenged with the Beta and Delta variants on day 56. Oral swabs were obtained from all the study subjects on day 4, while lung, cerebrum, and cerebellum samples were collected on day 10. Furthermore, the team examined if lower concentrations of either monovalent or bivalent vaccines could stimulate lung parenchymal tissue-resident T cells. 

Results

The study results showed that among the NaCl-injected mice exposed to SARS-CoV-2, all the Beta-exposed and 67% of the Delta-exposed mice succumbed to the infection. The team found no detectable amounts of SARS-CoV-2 genomic RNA or subgenomic RNA (sgRNA) in the oral swabs or the lung, cerebrum, and cerebellum samples in all bivalent-vaccinated Beta-challenged mice, except for one. This indicated that productive infection was significantly prevented in the infected mice.

However, the team noted that the prevention of SARS-CoV-2 replication by the monovalent vaccines in the upper respiratory tract (URT) was dependent on the virus exposed to the mice. The reduced viral load found in the conchae of the bivalent-vaccinated mice was equivalent to that in the matched monovalent-vaccinated mice after being exposed to Beta. However, the viral replication of the Delta variant was entirely prevented in all the vaccinated cohorts.

Furthermore, the team reported high levels of anti-receptor binding domain (RBD) total immunoglobulin levels in all the vaccinated mice. Also, the bivalent and the monovalent vaccines induced equally high levels of neutralizing antibodies in their respective Beta- and Delta-exposed mice. Overall, the levels of neutralizing antibodies elicited by the bivalent vaccines were statistically higher than that of the monovalent vaccines, irrespective of the variant.         

Moreover, the lower concentrations of the monovalent and the bivalent vaccines induced potent SARS-CoV-2 spike protein-specific CD4+ and CD8+ responses as compared to the non-vaccinated mice. The vaccination also triggered the enrichment of interferon-gamma and granzyme-B in the lung parenchyma.

Conclusion

The study findings showed that the effective viral clearance of the SARS-CoV-2 Delta variant observed in the mice conchae necessitates the evaluation of vaccine effectiveness of bivalent vaccines as well as of vaccines with higher valencies. The researchers believe that mRNA vaccines can be further developed to adapt to circulating and emerging SARS-CoV-2 variants.

*Important notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: A method for variant agnostic detection of SARS-CoV-2, rapid monitoring of circulating variants, detection of mutations of biological significance, and early detection of emergent variants such as Omicron. Image Credit: Lightspring/Shutterstock

New method for monitoring circulating SARS-CoV-2 variants and detecting new ones

by Medical Finance
May 20, 2022
0

After more than two years of the coronavirus disease (COVID-19) pandemic, there is still a constant threat of evolving strains...

Providing recombinant antibody services and more within Europe

Providing recombinant antibody services and more within Europe

by Medical Finance
May 20, 2022
0

In this interview, News-Medical talks to Dr. Zhang Linlin, Technical Specialist at Sino Biological Europe, about their recombinant antibody services...

Study: Temporary hold of mycophenolate boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients. Image Credit: PhotobyTawat/Shutterstock

Withdrawing steroid treatment found to boost SARS-CoV-2 vaccine-induced immunity in kidney transplant recipients

by Medical Finance
May 20, 2022
0

In a recent study posted to the medRxiv* pre-print server, a team of researchers investigated the impact of the fourth...

Fire closes hospital and displaces staff as Colorado battles omicron

Is my cloth mask good enough? The 2022 edition

by Medical Finance
May 20, 2022
0

The highly transmissible omicron variant is sweeping the U.S., causing a huge spike in covid-19 cases and overwhelming many hospital...

Study: Evaluating Real-World COVID-19 Vaccine Effectiveness Using a Test-Negative Case-Control Design. Image Credit: siam.pukkato/Shutterstock

Real-world effectiveness of three COVID-19 vaccines

by Medical Finance
May 20, 2022
0

The mass lockdowns and restrictions imposed by governments to prevent the spread of coronavirus disease 2019 (COVID-19) were dominant...

Study: Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19: preclinical studies and randomized controlled phase 1 clinical trial. Image Credit: NIAID

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

by Medical Finance
May 20, 2022
0

Coronavirus disease 2019 (COVID-19), caused by the rapid outbreak of severe acute respiratory disease coronavirus-2 (SARS-CoV-2), has claimed more than...

Next Post
Dog brains can detect speech and show different activity patterns to many languages

New drug inhibits growth of the most aggressive meningiomas

Study: BNT162b2 post-exposure-prophylaxis against COVID-19. Image Credit: Rido/Shutterstock

Impact of post-exposure BNT162b2 prophylaxis against SARS-CoV-2 infections

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection. Image Credit: Kateryna Kon/Shutterstock
    Study explores incidence of cardiac impairment a year after SARS-CoV-2 infection
  • Study: Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation. Image Credit: Horth Rasur/Shutterstock
    Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply